2014
DOI: 10.5455/2320-1770.ijrcog20140938
|View full text |Cite
|
Sign up to set email alerts
|

Alpha methyldopa induced hepatotoxicity in pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 8 publications
(5 reference statements)
0
1
0
Order By: Relevance
“…Methyldopa considered as the drug of choice in the treatment of non-complicated pregnancy-induced hypertension. The centrally acting sympatholytic action of methyldopa is responsible for its therapeutic effect in the treatment of hypertension during pregnancy which reduces the sympathetic drive to the heart and peripheral circulation, resulting in lowering cardiac output and decrease peripheral vascular resistance 29 . However, methyldopa may cause hepatic necrosis through immunological reaction and there is some evidence support the immunological mechanism such as the absence of a dose relationship and the absence of toxicity in animals, also clinical study indicated that some patient receiving methyldopa and suffering from hepatitis associated with rash or fever, further suggesting a hypersensitivity reaction 30 .…”
Section: Methyldopamentioning
confidence: 99%
“…Methyldopa considered as the drug of choice in the treatment of non-complicated pregnancy-induced hypertension. The centrally acting sympatholytic action of methyldopa is responsible for its therapeutic effect in the treatment of hypertension during pregnancy which reduces the sympathetic drive to the heart and peripheral circulation, resulting in lowering cardiac output and decrease peripheral vascular resistance 29 . However, methyldopa may cause hepatic necrosis through immunological reaction and there is some evidence support the immunological mechanism such as the absence of a dose relationship and the absence of toxicity in animals, also clinical study indicated that some patient receiving methyldopa and suffering from hepatitis associated with rash or fever, further suggesting a hypersensitivity reaction 30 .…”
Section: Methyldopamentioning
confidence: 99%